Funded Tech Companies
Pluristyx
Wondering who invested in Pluristyx? BioLife Solutions, BroadOak Capital Partners and private investors joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Pluristyx
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
3000 Western Ave
Seattle, WA 98121
USA
Seattle, WA 98121
USA
Phone
Website
Email Address
Company Background Information
Overview
Established in 2018 as an advanced therapy tools company, Pluristyx helps companies and researchers solve manufacturing challenges in the field of drug development, regenerative medicine, and cell and gene therapy. Pluristyx has provided seamless support through CMC consulting, contract development services, and research- and clinical-grade Ready-to-Use (RTU�) and Ready-To-Differentiate (RTD®) Pluripotent Stem Cells at a commercial scale.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/28/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Benjamin Fryer
Chief Operating Officer
Jason Carstens
Chief Technical Officer
Brian Hawkins
VP - Finance
James Laing
Company Investors
- BioLife Solutions
- BroadOak Capital Partners
Browse more funded tech companies:
Plurilock Security Solutions | PluroGen Therapeutics
Share this article
About Our VC & M&A Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs